Fiera Capital Corp Alnylam Pharmaceuticals, Inc. Transaction History

Fiera Capital Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$128.63 - $176.89 $475,931 - $654,493	-3,700 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$126.83 - $175.69 $23,463 - $32,502	185 Added 5.26%	3,700 $522,000
Q4 2020 Feb 09, 2021	BUY	$122.97 - $147.0 $98,376 - $117,600	800 Added 29.47%	3,515 $457,000
Q3 2020 Nov 12, 2020	SELL	$121.19 - $165.49 $41,204 - $56,266	-340 Reduced 11.13%	2,715 $395,000
Q2 2020 Aug 07, 2020	BUY	$104.21 - $156.44 $318,361 - $477,924	3,055 New	3,055 $452,000

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Fiera Capital Corp with notifications on news.